{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:08:59Z","timestamp":1760368139177},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"DOI":"10.1186\/1471-2202-2-10","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:40:44Z","timestamp":1034361644000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Vasopressin-dependent flank marking in golden hamsters is suppressed by drugs used in the treatment of obsessive-compulsive disorder"],"prefix":"10.1186","volume":"2","author":[{"given":"Craig F","family":"Ferris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mads F","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Messenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Koppel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,8,15]]},"reference":[{"key":"11_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1126\/science.6538700","volume":"224","author":"CF Ferris","year":"1984","unstructured":"Ferris CF, Albers HE, Wesolowski SM, Goldman BD, Leeman SE: Vasopressin injected into the hypothalamus triggers a stereotypic behavior in golden hamsters. Science. 1984, 224: 521-523.","journal-title":"Science"},{"key":"11_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0167-0115(85)90067-9","volume":"12","author":"HE Albers","year":"1985","unstructured":"Albers HE, Ferris CF: Behavioral effects of vasopressin and oxytocin within the medial preoptic area of the golden hamster. Regal Peptides. 1985, 12: 257-260. 10.1016\/0167-0115(85)90067-9.","journal-title":"Regal Peptides"},{"key":"11_CR3","first-page":"121","volume-title":"In: The Hamster: Reproduction and Behavior. (Edited by Siege1HI), New York, Plenum Press","author":"RE Johnston","year":"1985","unstructured":"Johnston RE: Communication. In: The Hamster: Reproduction and Behavior. (Edited by Siege1HI), New York, Plenum Press. 1985, 121-154."},{"key":"11_CR4","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1523\/JNEUROSCI.06-07-02085.1986","volume":"6","author":"HE Albers","year":"1986","unstructured":"Albers HE, Pollock J, Simmons WH, Ferris CF: A V1l-like receptor mediates vasopressin-induced flank marking behavior in hamster hypothalamus. J Neurosci. 1986, 6: 2085-2089.","journal-title":"J Neurosci"},{"key":"11_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0014-2999(88)90092-1","volume":"154","author":"CF Ferris","year":"1988","unstructured":"Ferris CF, Singer EA, Meenan DM, Albers HE: Inhibition of vasopressin-stimulated flank marking behavior by V1-receptor antagonists. Eur J Pharmacol. 1988, 154: 153-159. 10.1016\/0014-2999(88)90092-1.","journal-title":"Eur J Pharmacol"},{"key":"11_CR6","first-page":"185","volume":"208","author":"CF Ferris","year":"1991","unstructured":"Ferris CF: Vasopressin and social behaviors in the golden hamster. In: Proceedings of the Third International Vasopressin Conference (Edited by Jard S, Jamison, R) Colloque INSERM\/John Libbey Eurotext Ltd. 1991, 208: 185-193.","journal-title":"In: Proceedings of the Third International Vasopressin Conference (Edited by Jard S, Jamison, R) Colloque INSERM\/John Libbey Eurotext Ltd"},{"key":"11_CR7","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/BF00212844","volume":"94","author":"G Fehm-Wolfsdorf","year":"1988","unstructured":"Fehm-Wolfsdorf G, Bacholz G, Born J, Voight K, Fehm HL: Vasopressin but not oxytocin enhances cortical arousal: an integrative hypothesis on the behavioral effects of neurohypophyseal hormones. Psychopharmacology (Berp). 1988, 94: 496-500.","journal-title":"Psychopharmacology (Berp)"},{"key":"11_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1113\/jphysiol.1979.sp012953","volume":"205","author":"KE Cooper","year":"1979","unstructured":"Cooper KE, Kasting NW, Lederis K, Veale WL: Evidence supporting a role for endogenous vasopressin in natural suppression of fever in the sheep. J Physiol. 1979, 205: 33-45.","journal-title":"J Physiol"},{"key":"11_CR9","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1210\/endo-110-3-1058","volume":"110","author":"QJ Pittman","year":"1982","unstructured":"Pittman QJ, Lawrence D, Mclean L: Central effects of arginine vasopressin on blood pressure in rats. Endocrinology. 1982, 110: 1058-1060.","journal-title":"Endocrinology"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1037\/0735-7044.113.4.804","volume":"113","author":"CF Ferris","year":"1999","unstructured":"Ferris CF, Stolberg T, Delville Y: Serotonin regulation of aggressive behavior in male golden hamsters Mesocricetus auratus). Behav Neurosci. 1999, 113: 804-815. 10.1037\/\/0735-7044.113.4.804.","journal-title":"Behav Neurosci"},{"key":"11_CR11","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1523\/JNEUROSCI.17-11-04331.1997","volume":"17","author":"CF Ferris","year":"1997","unstructured":"Ferris CF, Melloni RH, Perry KW, Fuller RW, Koppel G, Delville Y: Vasopressin\/serotonin interaction in the anterior hypothalamus control aggressive behavior in golden hamsters. J Neurosci. 1997, 17: 4331-4340.","journal-title":"J Neurosci"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/232058a0","volume":"232","author":"D De Wied","year":"1971","unstructured":"De Wied D: Long term effect of vasopressin on the maintenance of a conditioned avoidance response in rats. Nature. 1971, 232: 58-60.","journal-title":"Nature"},{"key":"11_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0167-0115(86)90009-1","volume":"14","author":"JD Caldwell","year":"1986","unstructured":"Caldwell JD, Drago F, Prange AJ, Pedersen CA: A comparison of grooming behavior potencies of neurohypophyseal nonapeptides. Regul Peptides. 1986, 14: 261-271. 10.1016\/0167-0115(86)90009-1.","journal-title":"Regul Peptides"},{"key":"11_CR14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/0018-506X(78)90037-5","volume":"11","author":"RL Delanoy","year":"1978","unstructured":"Delanoy RL, Dunn AJ, Tintner R: Behavioral responses to intracerebroventricularly administered neurohypophyseal peptides in mice. Horm Behav. 1978, 11: 348-362.","journal-title":"Horm Behav"},{"key":"11_CR15","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJM198305123081902","volume":"308","author":"PW Gold","year":"1983","unstructured":"Gold PW, Kaye W, Robertson G, Ebert M: Abnormalities in plasma and cerebrospinal fluid arginine vasopressin in patients with anorexia nervosa. N Engl J Med. 1983, 308: 1117-1123.","journal-title":"N Engl J Med"},{"key":"11_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/archpsyc.1992.01820010009002","volume":"49","author":"M Altemus","year":"1992","unstructured":"Altemus M, Pigott T, Kalogeras KT, Demitrack M, Dubbert B, Murphy DL, Gold PW: Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder. Arch Gen Psychiatry. 1992, 49: 9-20.","journal-title":"Arch Gen Psychiatry"},{"key":"11_CR17","first-page":"1277","volume":"74","author":"MA Demitrack","year":"1992","unstructured":"Demitrack MA, Kalogeras K, Altemus M, Pigott TA, Listwak SJ, Gold PW: Plasma and cerebrospinal fluid measures of arginine vasopressin in patients with bulimia nervosa and in healthy subjects. J Clin Endocrinol Metab. 1992, 74: 1277-1283.","journal-title":"J Clin Endocrinol Metab"},{"key":"11_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archpsyc.1992.01820010029004","volume":"49","author":"SE Swedo","year":"1992","unstructured":"Swedo SE, Leonard HL, Kruesi MI, Rettew DC, Listwak SI, Berrenttini W, Stipetic M, Hamburger S, Gold PW, Potter WZ, et al: Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder. Arch Gen Psychiatry. 1992, 49: 29-36.","journal-title":"Arch Gen Psychiatry"},{"key":"11_CR19","volume-title":"4th ed. Washington, DC: American Psychiatric Press","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders,. 4th ed. Washington, DC: American Psychiatric Press. 1994"},{"key":"11_CR20","first-page":"29","volume":"53","author":"WK Goodman","year":"1992","unstructured":"Goodman WK, McDougle CJ, Price LH: Pharmacotherapy of obsessive compulsive disorder. J Clin Psychiatry. 1992, 53: 29-37.","journal-title":"J Clin Psychiatry"},{"key":"11_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/BF00567009","volume":"5","author":"B Hamberger","year":"1975","unstructured":"Hamberger B, Tuck JR: Effect of tricyclic antidepressants on the uptake of noradrenaline and 5-hydroxy-tryptamine by rat brain slices incubated in buffer of human plasma. Eur J Clin Pharmacol. 1975, 5: 229-235.","journal-title":"Eur J Clin Pharmacol"},{"key":"11_CR22","first-page":"7","volume":"46","author":"P Stark","year":"1985","unstructured":"Stark P, Fuller RW, Wong DT: The pharmacological profile of fluoxetine. J Clin Psychiatry. 1985, 46: 7-13.","journal-title":"J Clin Psychiatry"},{"key":"11_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1001\/archpsyc.1995.03950130053006","volume":"52","author":"JH Greist","year":"1995","unstructured":"Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC: Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. Arch Gen Psychiatry. 1995, 52: 53-60.","journal-title":"Arch Gen Psychiatry"},{"key":"11_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0014-2999(84)90403-5","volume":"104","author":"E Richelson","year":"1984","unstructured":"Richelson E, Pfenning M: Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol. 1984, 104: 277-286. 10.1016\/0014-2999(84)90403-5.","journal-title":"Eur J Pharmacol"},{"key":"11_CR25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1001\/archpsyc.1992.01820070011002","volume":"49","author":"JL Rapoport","year":"1992","unstructured":"Rapoport JL, Ryland DH, Kriete M: Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder. Arch Gen Psychiatry. 1992, 49: 517-521.","journal-title":"Arch Gen Psychiatry"},{"key":"11_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/0006-3223(87)90199-5","volume":"22","author":"J Zohar","year":"1987","unstructured":"Zohar J, Insel TR: Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Biol Psychiatry. 1987, 22: 667-687. 10.1016\/0006-3223(87)90199-5.","journal-title":"Biol Psychiatry"},{"key":"11_CR27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJM198908243210803","volume":"321","author":"SE Swedo","year":"1989","unstructured":"Swedo SE, Leonard HL, Rapoport JL, Lenane M, Cheslow D, Goldberger E: A double-blind comparison of Chlomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med. 1989, 321: 497-501.","journal-title":"N Engl J Med"},{"key":"11_CR28","first-page":"118","volume-title":"In: Obsessive-Compulsive Disorders: Theory and Management (Edited by Jenike M, Baer L, Minichiello W), 2nd ed. St Louis: Mosby-Year Book","author":"TR Insel","year":"1990","unstructured":"Insel TR, Winslow J: Neurobiology of obsessive-compulsive disorder. In: Obsessive-Compulsive Disorders: Theory and Management (Edited by Jenike M, Baer L, Minichiello W), 2nd ed. St Louis: Mosby-Year Book. 1990, 118-131."},{"key":"11_CR29","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/0010-440X(92)90053-S","volume":"33","author":"DL Stein","year":"1992","unstructured":"Stein DL, Shoulberg N, Helton K, Hollander E: The neuroethological approach to obsessive-compulsive disorder. Comprehensive Psychiatry. 1992, 33: 274-281.","journal-title":"Comprehensive Psychiatry"},{"key":"11_CR30","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1001\/archpsyc.1991.01810320054008","volume":"48","author":"The Clomipramine Collaborative Study Group","year":"1991","unstructured":"The Clomipramine Collaborative Study Group: Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1991, 48: 730-738.","journal-title":"Arch Gen Psychiatry"},{"key":"11_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0924-977X(93)90266-O","volume":"3","author":"SA Montgomery","year":"1993","unstructured":"Montgomery SA, McIntyre A, Osterheider M, Sarteschi P, Zitterl W, Zohar J, Birkett M, Wood AJ: A double-blind, placebo-controlled study of fluoxetine in patients with DSM-II-R obsessive-compulsive disorder. The Lilly European OCD Study Group. Eur Neuropsychopharmacol. 1993, 3: 143-152. 10.1016\/0924-977X(93)90266-O.","journal-title":"Eur Neuropsychopharmacol"},{"key":"11_CR32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1001\/archpsyc.1994.03950070051010","volume":"51","author":"GD Tollefson","year":"1994","unstructured":"Tollefson GD, Rampey AH, Potvin JH, Jenike MA, Rush AJ, Kominguez RA, Koran LM, Shear MK, Goodman W, Genduso LA: A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 1994, 51: 559-567.","journal-title":"Arch Gen Psychiatry"},{"key":"11_CR33","doi-asserted-by":"publisher","first-page":"24S","DOI":"10.1097\/00004714-198712001-00003","volume":"7","author":"P Blier","year":"1987","unstructured":"Blier P, de Montigny C, Chaput Y: Modification of the serotonin system by antidepressant treatments: Implications for the therapeutic response in major depression. J Clin Psychopharmacol. 1987, 7: 24S-35S.","journal-title":"J Clin Psychopharmacol"},{"key":"11_CR34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0165-0173(96)00017-3","volume":"23","author":"R Mongeau","year":"1997","unstructured":"Mongeau R, Blier P, de Montigny C: The serotonergic and noradrenergic systems of the hippocampus: Their interactions and the effects of antidepressant treatments. Brain Res Rev. 1997, 23: 145-195. 10.1016\/S0165-0173(96)00017-3.","journal-title":"Brain Res Rev"},{"key":"11_CR35","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/0006-3223(85)90176-3","volume":"20","author":"TR Insel","year":"1985","unstructured":"Insel TR, Mueller EA, Alterman I, Linnoila , Murphy DL: Obsessive-compulsive disorder and serotonin: is there a connection?. Biol Psychiatry. 1985, 20: 1174-1188. 10.1016\/0006-3223(85)90176-3.","journal-title":"Biol Psychiatry"},{"key":"11_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0006-8993(92)91326-A","volume":"593","author":"M Altemus","year":"1992","unstructured":"Altemus M, Cizza G, Gold PW: Chronic fluoxetine treatment reduces hypothalamic vasopressin secretion in vitro. Brain Res. 1992, 593: 311-313. 10.1016\/0006-8993(92)91326-A.","journal-title":"Brain Res"},{"key":"11_CR37","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/0306-4530(94)90021-3","volume":"19","author":"JF Leckman","year":"1994","unstructured":"Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, Anderson GM, Riddle MA, McDougle CJ, Barr LC, et al: The role of central oxytocin in obsessive compulsive disorder and related normal behavior. Psychoneuroendocrinoly. 1994, 19: 723-749. 10.1016\/0306-4530(94)90021-3.","journal-title":"Psychoneuroendocrinoly"},{"key":"11_CR38","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1001\/archpsyc.1991.01810330081012","volume":"48","author":"H Grindlinger","year":"1991","unstructured":"Grindlinger H, Ramsey E: Compulsive feather picking in birds. Arch Gen Psychiatry. 1991, 48: 857.","journal-title":"Arch Gen Psychiatry"},{"key":"11_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0091-3057(95)02003-9","volume":"53","author":"M Altemus","year":"1996","unstructured":"Altemus M, Glowa JR, Galliven E, Leong Y-M, Murphy DL: Effects of serotonergic agents on food-restriction-induced hyperactivity. Pharmacol Biochem Behav. 1996, 53: 123-131. 10.1016\/0091-3057(95)02003-9.","journal-title":"Pharmacol Biochem Behav"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2202-2-10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T15:05:19Z","timestamp":1726239919000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/1471-2202-2-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8,15]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2001,12]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1186\/1471-2202-2-10","relation":{},"ISSN":["1471-2202"],"issn-type":[{"type":"electronic","value":"1471-2202"}],"subject":[],"published":{"date-parts":[[2001,8,15]]},"assertion":[{"value":"7 June 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"10"}}